Oxolamine dihydrogen citrate
Molecular Formula:
C20H27N3O8
InChI: InChI=1/C14H19N3O.C6H8O7/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-9H,3-4,10-11H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/fC14H20N3O.C6H7O7/h17H;7,11H/q+1;-1
InChIKey: InChIKey=RBZIGQJSMCOHSS-ADSZHHJGCT
SMILES: CC[NH+](CC)CCC1=NC(=NO1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)[O-])(C(=O)O)O
Names:
AF 438
EINECS 217-760-6
Oxolamine citrate
Oxolamine dihydrogen citrate
SKF 9976
1,2,4-OXADIAZOLE, 5-(2-(DIETHYLAMINO)ETHYL)-3-PHENYL-, CITRATE
1949-20-8
3-carboxy-3,5-dihydroxy-5-oxo-pentanoate; diethyl-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]azanium
3-Phenyl-5-(beta-(diethylamino)ethyl)-1,2,4-oxadiazole citrate
5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate
959-14-8
Registries:
PubChem CID 16045
PubChem ID 159324
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|